Company Description

Eradivir is developing drugs that bind to diseased cells, serving as a beacon to guide the immune system. Examples of approved molecules include a radiotherapy drug for prostate cancer and an intraoperative imaging agent for lung and ovarian cancers. Several others are currently in clinical trials (e.g., treatments for cancer, malaria, and sickle cell anemia).